Skip to main
ZTS

Zoetis (ZTS) Stock Forecast & Price Target

Zoetis (ZTS) Analyst Ratings

Based on 11 analyst ratings
Buy
Strong Buy 27%
Buy 18%
Hold 55%
Sell 0%
Strong Sell 0%

Bulls say

Zoetis is a well-established, dominant player in the animal health market, with a strong presence in both production and companion animals. While competition and slower product adoption may pose challenges in the short term, the company's strategic plans and initiatives, such as new product launches and expansion into new therapeutic areas, suggest potential for long-term growth. Additionally, the increasing demand for animal health products in both established and emerging markets bodes well for Zoetis' continued success and financial stability.

Bears say

Zoetis is the market leader in the animal health industry with a significant revenue share, but the financial analyst is concerned about the potential cannibalization of its leading products due to the introduction of competing products and the company's reliance on a few top-selling products for a large portion of its revenue. Additionally, the analyst believes that the current market for animal health products may be facing some challenges, with potential staffing shortages, inflationary pressures, and muted growth rates. Furthermore, the analyst is also cautious about potential government regulations and competition from well-capitalized companies in the same industry. Overall, the analyst has a negative outlook on Zoetis's stock due to these concerns and believes that the stock is currently overvalued.

Zoetis (ZTS) has been analyzed by 11 analysts, with a consensus rating of Buy. 27% of analysts recommend a Strong Buy, 18% recommend Buy, 55% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Zoetis and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Zoetis (ZTS) Forecast

Analysts have given Zoetis (ZTS) a Buy based on their latest research and market trends.

According to 11 analysts, Zoetis (ZTS) has a Buy consensus rating as of Apr 28, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $155.18, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $155.18, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Zoetis (ZTS)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.